BURCAR ALISON D 4
4 · ICU MEDICAL INC/DE · Filed Mar 8, 2019
Insider Transaction Report
Form 4
BRUMMETT BURCAR ALISON
Vice President Marketing
Transactions
- Exercise/Conversion
Common Stock
2019-03-06+10,929→ 11,699 total - Tax Payment
Common Stock
2019-03-06−5,163→ 6,536 total - Exercise/Conversion
Common Stock
2019-03-06−3,643→ 0 totalExp: 2019-03-06→ Common Stock (10,929 underlying)
Footnotes (4)
- [F1]These Securities are Performance-based Restricted Stock Units (PRSU).
- [F2]There is neither a purchase price nor an exercise price for the PRSUs.
- [F3]Each PRSU reflects the contingent right to receive a variable number of shares of common stock based on achieving performance goals. At the determination date, based on certification of the achievement of the performance criteria, the reporting person earned 300% of the target award amount.
- [F4]These PRSUs were granted on February 5, 2016. The vesting for these PRSUs is dependent upon the achievement of performance criteria related to the Company's fiscal year 2018 Adjusted EBITDA per share CAGR in comparison to the fiscal year 2015 Adjusted EBITDA per weighted average basic share. The reporting person may potentially earn 100% to 300% of the target award amount originally reported on the date of grant.